T1	Participants 207 262	adults with smear-positive pulmonary tuberculosis (TB),
T2	Participants 324 432	human immunodeficiency virus (HIV) infected participants who were not receiving antiretroviral therapy (ART)
T3	Participants 698 714	750 participants
T4	Participants 1195 1220	HIV-infected participants
T5	Participants 1029 1054	HIV-infected participants
T6	Participants 1374 1394	HIV-infected persons
T7	Participants 1558 1578	HIV-infected persons
